prostate;bph/luts; mist; itind implant

* Over the past decade, 4 BPH stents have received FDA approval, with 2 nitinol-based stents—Zenflow and ProVee—entering the market in late 2025, marking a significant expansion of office-based treatment options. * Zorn places the rise of MISTs within the broader context of an aging male...